Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

IDH2 R172 mutation is associated with improved survival in IDH-mutated AML/MDS patients undergoing allogeneic stem cell transplantation: A geth-TC multicenter study

Ana Perez Gonzalez, Víctor Navarro Garces, Manuel Guerreiro, Marta Villalba Montaner, Alejandro Avendaño, Estefanía Pérez López, Ana Pilar Gonzalez, Alberto Mussetti, Rocio Parody, Mi Kwon, Irene García-Cadenas, Eva Bandres, Teresa Zudaire, Izarbe Delgado, Oriana López Godino, Olga Salamero, Guillermo Orti

Blood (2025) 146 (Supplement 1): 6082.

https://doi.org/10.1182/blood-2025-6082

Published: 2025

Journal Articles

Characterization and risk factors of transplantation-associated thrombotic microangiopathy (TA-TMA): Increased incidence associated to post-transplant cyclophosphamide (PTCy) prophylaxis.

Monica Cabrero, Diego Clavo Martin, Carmen Rodriguez, Jesus Zahinos, Estefanía Pérez López, Ana Africa Martin Lopez, Mónica Baile González, Alejandro Avendaño, Almudena Cabero Martinez, Ana García-Bacelar, Rodrigo Gil Manso, Maria Cortes-Rodriguez, María Lourdes Vázquez-López, Fermin Sanchez-Guijo, Lucia Lopez-Corral

Blood (2025) 146 (Supplement 1): 7729.

https://doi.org/10.1182/blood-2025-7729

Published: 2025

Journal Articles

Donor age matters: Selecting 10/10 muds under 35 enhances survival after ptcy allo-HCT

Blood (2025) 146 (Supplement 1): 7825.

https://doi.org/10.1182/blood-2025-7825

Published: 2025

Journal Articles

Younger donors, better outcomes: The impact of donor age in haploidentical transplantation for acute myeloid leukemia. study conducted on behalf of geth-TC

Blood (2025) 146 (Supplement 1): 6070.

https://doi.org/10.1182/blood-2025-6070

Published: 2025

Journal Articles

The evaluation of the HLA-KIR interaction models may predict the NK alloreactivity in haplo-HSCT based on ptcy: Experience of a single spanish center

Francisco Javier Gil Etayo, Rodrigo Gil-Manso, JAIRO EDUARDO NIÑO RAMÍREZ, Marta Fonseca-Santos, JUAN LÓPEZ-PÉREZ, ISABEL JIMÉNEZ HERNAZ, ARIADNA VICENTE PARRA, PILAR TERRADILLOS SÁNCHEZ, NURIA CALZADA, DANIEL ARROYO-SÁNCHEZ, FRANCISCO BOIX, Almudena Navarro-Bailón, SARA MARCOS ASENSIO, Estefanía Pérez López, Ramon Garcia-Sanz, Fermin Sanchez-Guijo, Lucia Lopez Corral, AMALIA TEJEDA VELARDE

Blood (2025) 146 (Supplement 1): 4296.

https://doi.org/10.1182/blood-2025-4296

Published: 2025

Journal Articles

The dimorphism at the HLA-B leader and molecular HLA compatibility impact on haplo-HSCT: Experience of a single-center based on ptcy strategies

Blood (2025) 146 (Supplement 1): 2471.

https://doi.org/10.1182/blood-2025-2471

Published: 2025

Journal Articles

Evaluating Plasma Extracellular Vesicles As Biomarkers of Inflammation and Outcome in Diffuse Large B-Cell Lymphoma Patients Undergoing CAR-T Therapy

Sandra Muntion, Almudena Navarro-Bailon, Martin Gomez-Redondo, Silvia Preciado, Lucía López-Corral, Miriam Lopez Parra, Eva M Villaron, Ana Africa Martin Lopez, Estefanía Pérez López, Fermin Sanchez-Guijo

Blood (2024) 144 (Supplement 1): 7156.

https://doi.org/10.1182/blood-2024-208573

Published: 2024

Journal Articles

Sativex Oromucosal Spray in Patients with Chronic Graft Versus Host Disease: Effect on Sclerodermal Features and Refractory Muscle Cramps

Rodrigo Gil Manso, Cristina Hidalgo, Laura Puebla Tornero, Almudena Cabero Martínez, Ana García Bacelar, Ana Africa Martin Lopez, Monica Cabrero Calvo, Monica Baile Gonzalez, Estefanía Pérez López, Alejandro Avendaño Pita, Lourdes Vazquez Lopez, Jenifer Alonso Rodriguez, Fermin Sanchez-Guijo, Lucia Lopez Corral

Blood (2024) 144 (Supplement 1): 2156.

https://doi.org/10.1182/blood-2024-206052

Published: 2024

Journal Articles

Current Prophylaxis and Treatment of Gvhd: Analysis of a Large Real-World Cohort. Spanish Group of Hematopoietic Transplantation and Cellular Therapy (GETH/TC)

Blood (2024) 144 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2024-203251

Published: 2024

Journal Articles

Impact of Ptcy on Early Cardiac Toxicity after HLA-Matched Allo-HCT in Patients with Acute Myeloid Leukemia. Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Blood (2024) 144 (Supplement 1): 2108.

https://doi.org/10.1182/blood-2024-205181

Published: 2024

Journal Articles

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation in a Spanish Multicenter Cohort on Behalf of Geth

Blood (2024) 144 (Supplement 1): 4884.

https://doi.org/10.1182/blood-2024-204722

Published: 2024

Journal Articles

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

Blood (2023) 142 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2023-185757

Published: 2023

Journal Articles

MO-TRANS: A Phase 2b Placebo-Controlled Study of Mocravimod As Adjunctive and Maintenance Treatment in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplant

Marcos de Lima, Florent Malard, Eduardo Olavarria, Estefanía Pérez López, Michael Medinger, Elisabeth Kueenburg, Malika Souquieres, Julien Cachat, Christos Stylianou, Patrice Chevallier

Blood (2022) 140 (Supplement 1): 12936–12937.

https://doi.org/10.1182/blood-2022-159785

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT

Blood (2022) 140 (Supplement 1): 10547–10549.

https://doi.org/10.1182/blood-2022-162546

Published: 2022

Journal Articles

Intestinal Transplant-Associated Thrombotic Microangiopathy: Histopathological Review. a Single Center Experience

Javier Checa, Óscar Javier Blanco Núñez, MD, Estefania Pérez-López, MD, Mónica Cabrero, MD, Ana A. Martín, MD, Daniel Rivera, MD, Alejandro Avendaño Pita, MD, Antonio velasco Guardado, PhD, Miguel Alcoceba, PhD, Luis Miguel Chinchilla Tábora, MD, Dolores Caballero, MD, Lucia Lopez Corral, PhD MD

Blood (2018) 132 (Supplement 1): 3385.

https://doi.org/10.1182/blood-2018-99-114587

Published: 2018

Journal Articles

Mesenchymal Stromal Cells for Refractory Acute Graft-Versus-Host Disease By Compassionate Use Provide Comparable Results to Those of Phase II Clinical Trials

Alvaro Veiga, MD, Alba Redondo, MD, Miriam López-Parra, MD, Olga López-Villar, MD, Eva Villarón, Maria Díez-Campelo, MD PhD, Daniel Rivera, MD, Natalia Espinosa, MD, Nerea Arratibel, MD, Mónica Baile, MD, Estefania Pérez-López, MD, Mónica Cabrero, MD, Ana A. Martín, MD, Lourdes Vázquez, MD, Lucía López Corral, MD, Dolores Caballero, MD PhD, Consuelo Del Cañizo, MDPhD, Fermin Sanchez-Guijo, MD PhD

Blood (2017) 130 (Supplement 1): 1981.

https://doi.org/10.1182/blood.V130.Suppl_1.1981.1981

Published: 2017

Journal Articles

CCR6, IL7R, FAS and Madcam-1 Single Nucleotide Polymorphisms Are Associated with Higher Incidence of Infections in Allogeneic Stem-Cell Transplant from a Related Donor after a Reduced Intensity Conditioning Regimen: A Multicenter Experience

Blood (2017) 130 (Supplement 1): 3208.

https://doi.org/10.1182/blood.V130.Suppl_1.3208.3208

Published: 2017

Journal Articles

Usefulness of Thrombopoietin Receptor Agonists for Thrombocytopenia after Allogeneic Stem Cell Transplantation. An Eight-Year Single Center Experience

Daniel Rivera, MD, Jose Maria Bastida, MDPhD, Lucia Lopez Corral, PhD MD, Fermin Sanchez-Guijo, MD PhD, Lourdes Vázquez, MD, Monica Cabrero, MD, Estefania Pérez-López, MD, Miriam López-Parra, MD, Ana A. Martín, MD, Javier Carrillo, MD, Alejandro Avendaño, MD, Alvaro Veiga, MD, Monica Baile, MD, Nerea Arratibel, MD, Dolores Caballero, MD PhD, Consuelo Del Cañizo, MDPhD, Jose Ramon González-Porras, MDPhD

Blood (2017) 130 (Supplement 1): 3222.

https://doi.org/10.1182/blood.V130.Suppl_1.3222.3222

Published: 2017

Journal Articles

Minimal Residual Diease Evaluation By Flow Cytometry Is a Complementary Tool To Cytogenetics For Treatment Decision In Acute Myeloid Leukemia

Blood (2013) 122 (21): 2576.

https://doi.org/10.1182/blood.V122.21.2576.2576

Published: 2013

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

IDH2 R172 mutation is associated with improved survival in IDH-mutated AML/MDS patients undergoing allogeneic stem cell transplantation: A geth-TC multicenter study

Characterization and risk factors of transplantation-associated thrombotic microangiopathy (TA-TMA): Increased incidence associated to post-transplant cyclophosphamide (PTCy) prophylaxis.

Donor age matters: Selecting 10/10 muds under 35 enhances survival after ptcy allo-HCT

Younger donors, better outcomes: The impact of donor age in haploidentical transplantation for acute myeloid leukemia. study conducted on behalf of geth-TC

The evaluation of the HLA-KIR interaction models may predict the NK alloreactivity in haplo-HSCT based on ptcy: Experience of a single spanish center

The dimorphism at the HLA-B leader and molecular HLA compatibility impact on haplo-HSCT: Experience of a single-center based on ptcy strategies

Evaluating Plasma Extracellular Vesicles As Biomarkers of Inflammation and Outcome in Diffuse Large B-Cell Lymphoma Patients Undergoing CAR-T Therapy

Sativex Oromucosal Spray in Patients with Chronic Graft Versus Host Disease: Effect on Sclerodermal Features and Refractory Muscle Cramps

Current Prophylaxis and Treatment of Gvhd: Analysis of a Large Real-World Cohort. Spanish Group of Hematopoietic Transplantation and Cellular Therapy (GETH/TC)

Impact of Ptcy on Early Cardiac Toxicity after HLA-Matched Allo-HCT in Patients with Acute Myeloid Leukemia. Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation in a Spanish Multicenter Cohort on Behalf of Geth

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

MO-TRANS: A Phase 2b Placebo-Controlled Study of Mocravimod As Adjunctive and Maintenance Treatment in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplant

Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT

Intestinal Transplant-Associated Thrombotic Microangiopathy: Histopathological Review. a Single Center Experience

Mesenchymal Stromal Cells for Refractory Acute Graft-Versus-Host Disease By Compassionate Use Provide Comparable Results to Those of Phase II Clinical Trials

CCR6, IL7R, FAS and Madcam-1 Single Nucleotide Polymorphisms Are Associated with Higher Incidence of Infections in Allogeneic Stem-Cell Transplant from a Related Donor after a Reduced Intensity Conditioning Regimen: A Multicenter Experience

Usefulness of Thrombopoietin Receptor Agonists for Thrombocytopenia after Allogeneic Stem Cell Transplantation. An Eight-Year Single Center Experience

Minimal Residual Diease Evaluation By Flow Cytometry Is a Complementary Tool To Cytogenetics For Treatment Decision In Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only